fluprednisolone has been researched along with Ocular Hypertension in 6 studies
Fluprednisolone: A synthetic glucocorticoid with anti-inflammatory properties.
Ocular Hypertension: A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare intraocular pressure (IOP) outcomes between 2 common, commercially available corticosteroid drops: difluprednate ophthalmic emulsion 0." | 7.85 | Comparison of prednisolone acetate 1.0% and difluprednate ophthalmic emulsion 0.05% after cataract surgery: Incidence of postoperative steroid-induced ocular hypertension. ( Ernest, P; McBain, M; Mian, SI; Musch, DC; Niziol, LM; Person, E; Tijunelis, MA, 2017) |
| "To identify changes in intraocular pressure (IOP) after vitreoretinal surgical procedures in eyes that received either difluprednate ophthalmic emulsion 0." | 7.80 | Incidence of steroid-induced ocular hypertension after vitreoretinal surgery with difluprednate versus prednisolone acetate. ( Connors, DB; Fine, HF; Jeng, KW; Prenner, JL; Roth, D; Wheatley, HM, 2014) |
| "To evaluate the clinical effect of topical difluprednate in pediatric patients for treatment of noninfectious uveitis." | 7.78 | Efficacy and potential complications of difluprednate use for pediatric uveitis. ( Herlihy, E; Ongchin, S; Slabaugh, MA; van Gelder, RN, 2012) |
| "To report the effects of twice-daily difluprednate in a child with pars planitis (PP)." | 7.77 | Effects of twice-daily topical difluprednate 0.05% emulsion in a child with pars planitis. ( Chheda, LV; Kurz, DE; Kurz, PA, 2011) |
| "To compare intraocular pressure (IOP) outcomes between 2 common, commercially available corticosteroid drops: difluprednate ophthalmic emulsion 0." | 3.85 | Comparison of prednisolone acetate 1.0% and difluprednate ophthalmic emulsion 0.05% after cataract surgery: Incidence of postoperative steroid-induced ocular hypertension. ( Ernest, P; McBain, M; Mian, SI; Musch, DC; Niziol, LM; Person, E; Tijunelis, MA, 2017) |
| "To identify changes in intraocular pressure (IOP) after vitreoretinal surgical procedures in eyes that received either difluprednate ophthalmic emulsion 0." | 3.80 | Incidence of steroid-induced ocular hypertension after vitreoretinal surgery with difluprednate versus prednisolone acetate. ( Connors, DB; Fine, HF; Jeng, KW; Prenner, JL; Roth, D; Wheatley, HM, 2014) |
| "To evaluate the clinical effect of topical difluprednate in pediatric patients for treatment of noninfectious uveitis." | 3.78 | Efficacy and potential complications of difluprednate use for pediatric uveitis. ( Herlihy, E; Ongchin, S; Slabaugh, MA; van Gelder, RN, 2012) |
| "To report the effects of twice-daily difluprednate in a child with pars planitis (PP)." | 3.77 | Effects of twice-daily topical difluprednate 0.05% emulsion in a child with pars planitis. ( Chheda, LV; Kurz, DE; Kurz, PA, 2011) |
| "Difluprednate 0." | 1.36 | Intraocular pressure elevation from topical difluprednate use. ( Meehan, K; Sowka, J; Vollmer, L, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tijunelis, MA | 1 |
| Person, E | 1 |
| Niziol, LM | 1 |
| Musch, DC | 1 |
| Ernest, P | 1 |
| McBain, M | 1 |
| Mian, SI | 1 |
| Jeng, KW | 1 |
| Fine, HF | 1 |
| Wheatley, HM | 1 |
| Roth, D | 1 |
| Connors, DB | 1 |
| Prenner, JL | 1 |
| Kurz, PA | 1 |
| Chheda, LV | 1 |
| Kurz, DE | 1 |
| Meehan, K | 1 |
| Vollmer, L | 1 |
| Sowka, J | 1 |
| Birnbaum, AD | 1 |
| Jiang, Y | 1 |
| Tessler, HH | 1 |
| Goldstein, DA | 1 |
| Slabaugh, MA | 1 |
| Herlihy, E | 1 |
| Ongchin, S | 1 |
| van Gelder, RN | 1 |
6 other studies available for fluprednisolone and Ocular Hypertension
| Article | Year |
|---|---|
Comparison of prednisolone acetate 1.0% and difluprednate ophthalmic emulsion 0.05% after cataract surgery: Incidence of postoperative steroid-induced ocular hypertension.
Topics: Cataract Extraction; Fluprednisolone; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Ocul | 2017 |
Incidence of steroid-induced ocular hypertension after vitreoretinal surgery with difluprednate versus prednisolone acetate.
Topics: Emulsions; Female; Fluprednisolone; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Male; | 2014 |
Effects of twice-daily topical difluprednate 0.05% emulsion in a child with pars planitis.
Topics: Administration, Topical; Cataract; Child; Emulsions; Fluprednisolone; Glucocorticoids; Humans; Male; | 2011 |
Intraocular pressure elevation from topical difluprednate use.
Topics: Administration, Topical; Black or African American; Emulsions; Female; Fluprednisolone; Glucocortico | 2010 |
Elevation of intraocular pressure in patients with uveitis treated with topical difluprednate.
Topics: Administration, Topical; Adolescent; Adult; Child; Fluprednisolone; Glucocorticoids; Humans; Intraoc | 2011 |
Efficacy and potential complications of difluprednate use for pediatric uveitis.
Topics: Administration, Topical; Adolescent; Aqueous Humor; Cataract; Child; Female; Fluprednisolone; Glucoc | 2012 |